Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Dongfang Pharmaceutical is a comprehensive pharmaceutical enterprise based in China that specializes in the research, development, and manufacturing of chemical drugs and Traditional Chinese Medicines (TCM). The company operates large-scale production facilities for various dosage forms, including small-volume injections, tablets, capsules, and granules. Its product portfolio primarily focuses on anti-infectives, cardiovascular treatments, and respiratory medications. Dongfang Pharmaceutical is recognized for its GMP-certified manufacturing capabilities and serves both domestic and international markets with a range of generic and proprietary formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dongfang Pharmaceutical.